(InSilico Medicine, Inc.) The latest publication by Insilico Medicine and BioTime in Oncotarget demonstrated the first application of deep neural networks (DNNs) to the gene expression data collected during many stages of differentiation starting from several embryonic stem cell lines. Repression of COX7A1 in embryonic and cancer cells was identified as embryonic-fetal transition markers by DNN.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2CI1zPq
No comments:
Post a Comment